标题
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
作者
关键词
-
出版物
Nature Reviews Neurology
Volume 14, Issue 11, Pages 639-652
出版商
Springer Nature America, Inc
发表日期
2018-10-08
DOI
10.1038/s41582-018-0079-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment
- (2018) Yong Shen et al. BIOLOGICAL PSYCHIATRY
- Untangling Genetic Risk for Alzheimer’s Disease
- (2018) Anna A. Pimenova et al. BIOLOGICAL PSYCHIATRY
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- A Blood Test for Alzheimer’s Disease: Progress, Challenges, and Recommendations
- (2018) Steven J. Kiddle et al. JOURNAL OF ALZHEIMERS DISEASE
- Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
- (2018) Harald Hampel et al. JOURNAL OF ALZHEIMERS DISEASE
- Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
- (2018) Bruno Dubois et al. LANCET NEUROLOGY
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Sex differences in Alzheimer disease — the gateway to precision medicine
- (2018) Maria Teresa Ferretti et al. Nature Reviews Neurology
- Precision pharmacology for Alzheimer’s disease
- (2018) Harald Hampel et al. PHARMACOLOGICAL RESEARCH
- Validation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues
- (2018) Sid E. O'Bryant et al. JOURNAL OF ALZHEIMERS DISEASE
- Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
- (2017) Filippo Baldacci et al. Expert Review of Proteomics
- Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study
- (2017) Saima Hilal et al. JOURNAL OF ALZHEIMERS DISEASE
- A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer’s Disease
- (2017) Rui Guo et al. JOURNAL OF ALZHEIMERS DISEASE
- Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
- (2017) Giovanni B Frisoni et al. LANCET NEUROLOGY
- Bridging the translational innovation gap through good biomarker practice
- (2017) Alain J. van Gool et al. NATURE REVIEWS DRUG DISCOVERY
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging
- (2017) Michelle M. Mielke et al. JAMA Neurology
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- 2016 Alzheimer's disease facts and figures
- (2016) Alzheimers & Dementia
- Validating Alzheimer's disease micro RNAs using next-generation sequencing
- (2016) Andreas Keller et al. Alzheimers & Dementia
- Genomic variants, genes, and pathways of Alzheimer's disease: An overview
- (2016) Adam C. Naj et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia
- (2016) Bryan D. James et al. BRAIN
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus
- (2016) Benjamin Roeben et al. JOURNAL OF ALZHEIMERS DISEASE
- Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges
- (2016) Dana Kim et al. Journal of Clinical Neurology
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Biomarker Tests for Molecularly Targeted Therapies — The Key to Unlocking Precision Medicine
- (2016) Gary H. Lyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrative methods for analyzing big data in precision medicine
- (2016) Vladimir Gligorijević et al. PROTEOMICS
- Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
- (2016) Y. Iturria-Medina et al. Nature Communications
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
- (2016) Julio C. Rojas et al. Annals of Clinical and Translational Neurology
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Explorative and targeted neuroproteomics in Alzheimer's disease
- (2015) Ann Brinkmalm et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Amyloid imaging for dementia in clinical practice
- (2015) John T. O’Brien et al. BMC Medicine
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding
- (2015) Kaj Blennow et al. NATURE MEDICINE
- Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
- (2015) Axel Montagne et al. NEURON
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease
- (2015) Dilek Inekci et al. Frontiers in Neurology
- Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
- (2014) Kai-Yuan Tzen et al. ACS Chemical Neuroscience
- Plasma proteins predict conversion to dementia from prodromal disease
- (2014) Abdul Hye et al. Alzheimers & Dementia
- Preferences of older people for early diagnosis and disclosure of Alzheimer's disease (AD) before and after considering potential risks and benefits
- (2014) Stephanie M. Robinson et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Brain metabolic dysfunction at the core of Alzheimer's disease
- (2014) Suzanne M. de la Monte et al. BIOCHEMICAL PHARMACOLOGY
- The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
- (2014) Johannes Attems et al. BMC Medicine
- Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future
- (2014) Harald Hampel et al. Expert Review of Neurotherapeutics
- Paths to Alzheimer’s disease prevention: From modifiable risk factors to biomarker enrichment strategies
- (2014) Simone Lista et al. Journal of Nutrition Health & Aging
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- The amyloid-β degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease
- (2014) Josef Pannee et al. NEUROSCIENCE LETTERS
- Prevalence of mixed pathologies in the aging brain
- (2014) Jasmin Rahimi et al. Alzheimers Research & Therapy
- Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series
- (2013) Gabor G. Kovacs et al. ACTA NEUROPATHOLOGICA
- Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
- (2013) Bruno Vellas et al. Alzheimers & Dementia
- The future of blood-based biomarkers for Alzheimer's disease
- (2013) Kim Henriksen et al. Alzheimers & Dementia
- CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
- (2013) Simone Lista et al. Alzheimers & Dementia
- Developing novel blood-based biomarkers for Alzheimer's disease
- (2013) Heather M. Snyder et al. Alzheimers & Dementia
- Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
- (2013) Harald Hampel et al. BIOCHEMICAL PHARMACOLOGY
- Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement
- (2013) Harald Hampel et al. Journal of Nutrition Health & Aging
- A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
- (2013) S C Burnham et al. MOLECULAR PSYCHIATRY
- Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease
- (2013) Paul S. Aisen et al. NATURE REVIEWS DRUG DISCOVERY
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
- (2013) Douglas Galasko et al. Alzheimers Research & Therapy
- Multiplex biomarkers in blood
- (2013) Veer Gupta et al. Alzheimers Research & Therapy
- Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease
- (2013) Rik Vandenberghe et al. NeuroImage-Clinical
- From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine
- (2013) Erfan Younesi et al. EPMA Journal
- Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot
- (2012) Harald Hampel et al. Alzheimers & Dementia
- Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
- (2012) James D. Doecke ARCHIVES OF NEUROLOGY
- Challenges and opportunities for oncology biomarker discovery
- (2012) Avisek Deyati et al. DRUG DISCOVERY TODAY
- Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease
- (2012) Guoxin Wu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- From inherited to sporadic AD—crossing the biomarker bridge
- (2012) Harald Hampel et al. Nature Reviews Neurology
- A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory
- (2012) Leroy Hood et al. New Biotechnology
- Blood and plasma-based proteomic biomarker research in Alzheimer's disease
- (2012) Simone Lista et al. PROGRESS IN NEUROBIOLOGY
- Biological and methodical challenges of blood-based proteomics in the field of neurological research
- (2012) Simone Lista et al. PROGRESS IN NEUROBIOLOGY
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Incidence of Post-Dural Puncture Headache in Research Volunteers
- (2011) Sérgio Monteiro de Almeida et al. HEADACHE
- Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention
- (2011) John Q. Trojanowski et al. PROGRESS IN NEUROBIOLOGY
- The role of genetics for biomarker development in neurodegeneration
- (2011) Lars Bertram et al. PROGRESS IN NEUROBIOLOGY
- Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements
- (2011) Karl Broich et al. PROGRESS IN NEUROBIOLOGY
- Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers
- (2010) Vladimir A. Krutovskikh et al. BIOESSAYS
- Blood-based biomarkers of Alzheimer’s disease: challenging but feasible
- (2010) Madhav Thambisetty et al. Biomarkers in Medicine
- A map of human genome variation from population-scale sequencing
- (2010) Richard M. Durbin et al. NATURE
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Biomarkers for Alzheimer's disease therapeutic trials
- (2010) Harald Hampel et al. PROGRESS IN NEUROBIOLOGY
- Primary Care Visit Duration and Quality
- (2009) Lena M. Chen ARCHIVES OF INTERNAL MEDICINE
- Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
- (2009) Philine Schneider et al. CNS Neuroscience & Therapeutics
- Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
- (2009) P. Lewczuk et al. EXPERIMENTAL NEUROLOGY
- Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels intoin vitrodiagnostics?
- (2009) Xavier Robin et al. Expert Review of Proteomics
- Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology
- (2009) Farshid Noorbakhsh et al. TRENDS IN NEUROSCIENCES
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
- (2008) O. L. Lopez et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started